# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1743536 | A | Mechanism based inhibition of human cytochrome P450 2A13 measured by coumarin 7-hydroxylation and testosterone 15-hydroxylation | Homo sapiens | 1 | ALA1743341 | single protein format | Scientific Literature | |
2. | ALA3532208 | A | Competitive inhibition of CYP2A13 (unknown origin) | Homo sapiens | 4 | ALA3526117 | single protein format | Scientific Literature | |
3. | ALA3532210 | A | Mixed inhibition of CYP2A13 (unknown origin) | Homo sapiens | 5 | ALA3526117 | single protein format | Scientific Literature | |
4. | ALA3535230 | A | Binding affinity to CYP2A13 (unknown origin) assessed as type 2 interaction as increase in absorbance 431 to 432 nm and decrease in 406 to 412 nm | Homo sapiens | 3 | ALA3526117 | single protein format | Scientific Literature | |
5. | ALA3535231 | A | Binding affinity to CYP2A13 (unknown origin) assessed as type 1 interaction as increase in absorbance 379 to 387 nm and decrease in 414 to 420 nm | Homo sapiens | 6 | ALA3526117 | single protein format | Scientific Literature | |
6. | ALA4418424 | B | Binding affinity to full length recombinant truncated non-catalytic N-terminal transmembrane helix containing C-terminal 4xHis tagged human CYP2A13dH expressed in Escherichia coli by HTS assay | Homo sapiens | 11 | ALA4418294 | assay format | Patent Bioactivity Data | |
7. | ALA4422428 | A | Inhibition of CYP2A13 (unknown origin) at 1 uM relative to control | Homo sapiens | 35 | ALA4421730 | single protein format | Patent Bioactivity Data |